UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 514

Sortiert nach

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

European journal of cancer (1990), 2013-07, Vol.49 (10), p.2294-2302

2013

Link zum Volltext

Verfügbarkeit prüfen

Expression of luminal and basal cytokeratins in human breast carcinoma

The Journal of pathology, 2004-06, Vol.203 (2), p.661-671

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

British journal of cancer, 2004-10, Vol.91 (8), p.1532-1542

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction

European journal of cancer (1990), 2000-10, Vol.36 (15), p.1938-1943

2000

Link zum Volltext

Verfügbarkeit prüfen

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

European journal of cancer (1990), 2007-07, Vol.43 (10), p.1548-1555

2007

Link zum Volltext

Verfügbarkeit prüfen

ONCOPOOL – A European database for 16,944 cases of breast cancer

European journal of cancer (1990), 2010-01, Vol.46 (1), p.56-71

2010

Link zum Volltext

Verfügbarkeit prüfen

EUSOMA accreditation of breast units

European journal of cancer (1990), 2006-07, Vol.42 (10), p.1331-1337

2006

Link zum Volltext

Verfügbarkeit prüfen

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

European journal of cancer (1990), 2009-07, Vol.45 (10), p.1780-1787

2009

Link zum Volltext

Verfügbarkeit prüfen

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

Annals of oncology, 2012-09, Vol.23 (9), p.2296-2300

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer—Final results at 20-year follow-up

Critical reviews in oncology/hematology, 2011-06, Vol.78 (3), p.260-264

2011

Link zum Volltext

Verfügbarkeit prüfen

The psychological impact of immediate rather than delayed breast reconstruction

European journal of surgical oncology, 2000-02, Vol.26 (1), p.17-19

2000

Link zum Volltext

Verfügbarkeit prüfen

Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials

Journal of clinical oncology, 2001-01, Vol.19 (2), p.343-353

2001

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine differentiation and prognosis in breast adenocarcinoma

Histopathology, 2002-03, Vol.40 (3), p.215-222

2002

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

European journal of cancer (1990), 2006-02, Vol.42 (3), p.357-362

2006

Link zum Volltext

Verfügbarkeit prüfen

Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?

European journal of surgical oncology, 1999-12, Vol.25 (6), p.571-573

1999

Link zum Volltext

Verfügbarkeit prüfen

Early-onset breast cancer - histopathological and prognostic considerations

British journal of cancer, 1997-05, Vol.75 (9), p.1318-1323

1997

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer

Clinical cancer research, 1999-08, Vol.5 (8), p.2069-2076

1999

Link zum Volltext

Verfügbarkeit prüfen

E-cadherin as a prognostic indicator in primary breast cancer

British journal of cancer, 2001-12, Vol.85 (12), p.1958-1963

2001

Link zum Volltext

Verfügbarkeit prüfen

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

European Journal of Cancer, 2003-05, Vol.39 (7), p.861-869

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

British journal of cancer, 1996-07, Vol.74 (2), p.300-308

1996

Link zum Volltext

Verfügbarkeit prüfen

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

Oncogene, 1998-10, Vol.17 (15), p.1949-1957

1998

Link zum Volltext

Verfügbarkeit prüfen

c-erbB-4 protein expression in human breast cancer

British journal of cancer, 2000-03, Vol.82 (6), p.1163-1170

2000

Link zum Volltext

Verfügbarkeit prüfen

The cosmetic outcome in early breast cancer treated with breast conservation

European journal of surgical oncology, 1999-12, Vol.25 (6), p.566-570

1999

Link zum Volltext

Verfügbarkeit prüfen

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

British journal of cancer, 1995-11, Vol.72 (5), p.1259-1266

1995

Link zum Volltext

Verfügbarkeit prüfen

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

European journal of cancer (1990), 1999-02, Vol.35 (2), p.214-218

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(484)
Mit Volltextzugriff
(412)

Publikationsform

Sprache

Englisch
(514)
Japanisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

Expression of luminal and basal cytokeratins in human breast carcinoma

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

ONCOPOOL – A European database for 16,944 cases of breast cancer

EUSOMA accreditation of breast units

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer—Final results at 20-year follow-up

The psychological impact of immediate rather than delayed breast reconstruction

Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials

Neuroendocrine differentiation and prognosis in breast adenocarcinoma

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma

Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?

Early-onset breast cancer - histopathological and prognostic considerations

Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer

E-cadherin as a prognostic indicator in primary breast cancer

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

c-erbB-4 protein expression in human breast cancer

The cosmetic outcome in early breast cancer treated with breast conservation

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

Suchergebnisse filtern